Fate Therapeutics (FATE) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Cowen Sees High Probability of Positive Data ASH at from Fate Therapeutics (FATE)
November 4, 2015 7:12 AM ESTCowen analyst Boris Peaker reiterated an Outperform rating on Fate Therapeutics (NASDAQ: FATE) and sees high probability of positive data at ASH.
Peaker commented, "Fate provided a pipeline update on its 3Q15 call as well as an overview of its... More

